TNF and neoplasm: Parallel investigations revealed that integrating TLR4 and/or IFN-γ receptor signaling modules into CAR architectures stimulated macrophages to upregulate M1-polarization markers—including CD86, MHC class II (MHC-II), and TNF-α—while accelerating tumor regression in preclinical models (69).